Raloxifene Hydrochloride

Labeled Rilpivirine, intended for use as an internal standard for the quantification of Rilpivirine by GC- or LC-mass spectrometry.

Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry.

Molecular formula: C11H9I3N2O4Molecular weight: 613.91

Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry.

Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.;Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry.

Labeled Propafenone, intended for use as an internal standard for the quantification of Propafenone by GC- or LC-mass spectrometry.

Labeled Tolterodine, intended for use as an internal standard for the quantification of Tolterodine by GC- or LC-mass spectrometry.

A dihydropyridine calcium channel blocker.;Labeled Lercanidipine, intended for use as an internal standard for the quantification of Lercanidipine by GC- or LC-mass spectrometry.

Labeled Ezetimibe, intended for use as an internal standard for the quantification of Ezetimibe by GC- or LC-mass spectrometry.

A labeled metabolite of Atorvastatin,;Labeled Atorvastatin, intended for use as an internal standard for the quantification of Atorvastatin by GC- or LC-mass spectrometry.

Labelled Clomiphene. Synthetic estrogen agonist-antagonist. Gonad-stimulating principle.;Labeled Clomiphene, intended for use as an internal standard for the quantification of Clomiphene by GC- or LC-mass spectrometry.

An antibiotic that blocks synthesis of dihydrofolic acid by inhibiting the enzyme dihydropteroate synthase

Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.